Cite
HARVARD Citation
Papi, A. et al. (2023). Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate‐to‐severe type 2 asthma. Allergy. 78 (1), pp. 233-243. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Papi, A. et al. (2023). Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate‐to‐severe type 2 asthma. Allergy. 78 (1), pp. 233-243. [Online].